Atacana Group > Resources Center > Reports > Antiviral Vaccines 2024 & 2025 Catalysts Report
Dark Mode

Antiviral Vaccines 2024 & 2025 Catalysts Report

Antiviral Vaccines 2024 & 2025 Catalysts Report
04/19/2024
04/19/2024
Atacana Group
Author

The antiviral vaccines space is about to see a flurry of events with regulatory approvals and launch announcements on the horizon.

  • Antivirals represent a substantial portion of the Global Anti-Infective Market
  • Industry leaders such as Pfizer, Moderna, GSK, and AstraZeneca expect pivotal advancements, including regulatory milestones, trial updates, and strategic launches
  • Notably, Moderna’s forthcoming events are top of mind, reinforcing its position as a key player in vaccine innovation

If you’re interested in getting a full copy of this report, download the report below

Vaccines 2024 & 2025 Catalysts Report

Name*(Required)